ABBIE STEINER: Open Payments
NPI 1558742197 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,480 in 148 payments from 16 companies in 2025. Trend: 2023 $1,016 · 2024 $1,999 · 2025 $2,480
Food & beverage: $2,480
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $450 |
| Otsuka America Pharmaceutical, Inc. | 22 | $445 |
| Alkermes, Inc. | 15 | $366 |
| Axsome Therapeutics, Inc. | 25 | $289 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $275 |
| Vanda Pharmaceuticals Inc. | 7 | $248 |
| PFIZER INC. | 6 | $111 |
| Indivior Inc. | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Tris Pharma Inc | 3 | $50 |
Products named: CAPLYTA, Auvelity, VRAYLAR, LYBALVI, ABILIFY ASIMTUFII, REXULTI, ARISTADA, FANAPT.
Industry payments across IN — which companies pay providers there.
